Bone metastases from solid tumors as osteolytic and/or osteoblastic.
Treatment of osteolytic lesions of multiple myeloma in combination with antineoplastic therapy.
Reduction of bone damage in patients with advanced malignancies involving bone.
Hypercalcemia of malignancy (HCM).
Sign Out